Association between human papillomavirus and oral cancer: a literature review.
Female
Humans
Mouth Neoplasms
Human Papillomavirus Viruses
Papillomavirus E7 Proteins
/ genetics
Papillomavirus Infections
/ complications
Carcinoma, Squamous Cell
/ pathology
DNA, Viral
/ genetics
Uterine Cervical Neoplasms
/ pathology
Human papillomavirus 16
/ genetics
Squamous Cell Carcinoma of Head and Neck
Head and Neck Neoplasms
Carcinogenesis
/ genetics
RNA, Messenger
Oncogene Proteins, Viral
/ genetics
Papillomaviridae
/ genetics
Human papillomavirus
Oral cancer
Oral epithelial dysplasia
Journal
International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
14
12
2022
accepted:
08
03
2023
medline:
23
10
2023
pubmed:
18
3
2023
entrez:
17
3
2023
Statut:
ppublish
Résumé
HPV plays a vital role in the development of cervical cancers and oropharyngeal cancers, but it is controversial whether HPV is involved in oral cancer development and to what extent. In this review, the clinical characteristics, diagnosis, treatment, and prognosis of HPV-positive oral cancers are summarized, and the mechanisms of HPV-related oral cancer development are discussed. HPV DNA positivity rates are 20-30% in oral squamous cell carcinoma (OSCC), and HPV16 is the most common high-risk HPV. E6/E7 mRNA positivity rates are 2-6% in OSCC. Detection of both high-risk HPV DNA and E6/E7 mRNA is recommended to determine the presence of active HPV, in agreement with high-risk HPV infection in OSCC. Surgical treatment is the first-line therapy for HPV-positive and -negative oral cancer, but there is no unified view about the prognosis of HPV-positive OSCC patients. HPV16 may play a vital role in malignant transformation in oral epithelial dysplasia, and a model of synergistic carcinogenic impact of HPV and tobacco smoking is predicted. Additionally, it is hypothesized that there are different HPV-associated oral cancers, such as integrated HPV DNA-positive OSCC with stable E6/E7 expression and episomal HPV DNA-positive OSCC. In summary, the role of HPV in oral carcinogenesis seems to be limited because of the low E6/E7 positivity in OSCCs; however, episomal HPV DNA may play a vital role in the malignant transformation of HPV-positive oral premalignant lesions. Further investigation is required to promote new insights into the role of episomal HPV DNA in oral carcinogenesis.
Identifiants
pubmed: 36929094
doi: 10.1007/s10147-023-02327-9
pii: 10.1007/s10147-023-02327-9
doi:
Substances chimiques
Papillomavirus E7 Proteins
0
DNA, Viral
0
RNA, Messenger
0
Oncogene Proteins, Viral
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
982-989Informations de copyright
© 2023. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.
Références
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
pubmed: 30207593
Ferlay J, Ervik M, Lam F, et al. (2018) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon. Available via DIALOG. https://gco.iarc.fr/today
Hussein AA, Helder MN, de Visscher JG et al (2017) Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer 82:115–127
pubmed: 28654785
Projected Cancer Statistics. Projected cancer incidence in 2022. ganjoho.jp. Available via DIALOG. https://ganjoho.jp/reg_stat/statistics/stat/short_pred_en.html
Kawakita D, Oze I, Iwasaki S et al (2022) Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan. Cancer Med 11:1553–1560
pubmed: 35029329
pmcid: 8921930
Morikawa T, Futoo E, Funakoshi A et al (2016) Clinical statistical study of oral cancer in young patients during 25 years in our department (in Japanese). Jpn J Oral Maxillofac Surg 62:144–150
Gholizadeh P, Eslami H, Yousefi M et al (2016) Role of oral microbiome on oral cancers, a review. Biomed Pharmacother 84:552–558
pubmed: 27693964
Foy JP, Bertolus C, Boutolleau D et al (2020) Arguments to support a viral origin of oral squamous cell carcinoma in non-smoker and non-drinker patients. Front Oncol 10:822
pubmed: 32528893
pmcid: 7253757
Doorbar J, Quint W, Banks L et al (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30(Suppl 5):F55-70
pubmed: 23199966
Gillison ML, Broutian T, Pickard RKL et al (2012) Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 307:693–703
pubmed: 22282321
pmcid: 5790188
D’Souza G, Cullen K, Bowie J et al (2014) Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One 9:e86023
pubmed: 24475067
pmcid: 3901667
Giraldi L, Collatuzzo G, Hashim D et al (2021) Infection with human papilloma virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiol 75:102020
pubmed: 34509873
Ndiaye C, Mena M, Alemany L et al (2014) HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 15:1319–1331
pubmed: 25439690
Kansy K, Thiele O, Freier K (2014) The role of human papillomavirus in oral squamous cell carcinoma: myth and reality. Oral Maxillofac Surg 18:165–172
pubmed: 23242943
Li H, Park HS, Osborn HA et al (2018) Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas. Cancers Head Neck 3:4
pubmed: 31093357
pmcid: 6460664
Lingen MW, Xiao W, Schmitt A et al (2013) Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 49:1–8
pubmed: 22841678
Nauta IH, Heideman DAM, Brink A et al (2021) The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma. Int J Cancer 149:420–430
pubmed: 33634865
pmcid: 8251537
Lewis JS Jr, Smith MH, Wang X et al (2022) Human papillomavirus-associated oral cavity squamous cell carcinoma: an entity with distinct morphologic and clinical features. Head Neck Pathol. https://doi.org/10.1007/s12105-022-01467-0
doi: 10.1007/s12105-022-01467-0
pubmed: 35802245
pmcid: 9729667
Rooper LM, Windon MJ, Hernandez T et al (2020) HPV-positive squamous cell carcinoma of the larynx, oral cavity, and hypopharynx: clinicopathologic characterization with recognition of a novel warty variant. Am J Surg Pathol 44:691–702
pubmed: 31934915
pmcid: 7885126
Yilmaz E, Ozbun MA, Gan GN et al (2021) Molecular and immune signature of HPV-positive oral cavity squamous cell carcinoma. Oral Oncol 116:105175
pubmed: 33509683
pmcid: 8519475
Gillison ML, Akagi K, Xiao W et al (2019) Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res 29:1–17
pubmed: 30563911
pmcid: 6314162
Durzynska J, Lesniewicz K, Poreba E (2017) Human papillomaviruses in epigenetic regulations. Mutat Res Rev Mutat Res 772:36–50
pubmed: 28528689
van Kempen PM, Noorlag R, Braunius WW et al (2014) Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics 9:194–203
pubmed: 24169583
Reis RSD, Santos JAD, Abreu PM et al (2020) Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma. Genet Mol Biol 43:e20190334
pubmed: 32870234
pmcid: 7452731
Prawdzic Seńkowska A, Kiczmer P et al (2019) Impact of HPV infection on gene expression and methylation in oral cancer patients. J Med Microbiol 68:440–445
pubmed: 30624179
Worsham MJ, Chen KM, Ghanem T et al (2013) Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg 149:409–416
pubmed: 23736812
pmcid: 3935612
Lechner M, Liu J, Masterson L et al (2022) HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 19:306–327
pubmed: 35105976
pmcid: 8805140
Japan Society of Clinical Oncology (2019) Clinical practice guidelines. jsco-cpg.jp.
Elango KJ, Suresh A, Erode EM et al (2011) Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev 12:889–896
pubmed: 21790221
Komolmalai N, Pongsiriwet S, Lertprasertsuke N et al (2020) Human papillomavirus 16 and 18 infection in oral cancer in Thailand: a multicenter study. Asian Pac J Cancer Prev 21:3349–3355
pubmed: 33247695
pmcid: 8033133
Isayeva T, Xu J, Ragin C et al (2015) The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways. Mod Pathol 28:631–653
pubmed: 25523612
Maeda K, Suzuki T, Ooyama Y et al (2010) Colorimetric analysis of unstained lesions surrounding oral squamous cell carcinomas and oral potentially malignant disorders using iodine. Int J Oral Maxillofac Surg 39:486–492
pubmed: 19963354
Ansarin M, Bruschini R, Navach V et al (2019) Classification of GLOSSECTOMIES: proposal for tongue cancer resections. Head Neck 41:821–827
pubmed: 30600861
pmcid: 6590454
Yoshino T, Hasegawa Y, Takahashi S et al (2013) Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial. Jpn J Clin Oncol 43:524–531
pubmed: 23479384
pmcid: 3638634
Motai R, Sawabe M, Kadowaki S et al (2021) Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma. Int J Clin Oncol 26:1188–1195
pubmed: 33821363
Chen L, Mo DC, Hu M et al (2022) PD-1/PD-L1 inhibitor monotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a meta-analysis. Am J Otolaryngol 43:103324
pubmed: 34923281
Ferris RL, Blumenschen G, Fayette J et al (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375:1856–1867
pubmed: 27718784
pmcid: 5564292
Yamakawa N, Umeda M, Yoshii Y et al (2022) Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma. Oral Dis. https://doi.org/10.1111/odi.14471
doi: 10.1111/odi.14471
pubmed: 36519515
Quayle SN, Girgis N, Thapa DR et al (2020) CUE-101, a novel E7-pHLA-IL2-Fc fusion protein, enhances tumor antigen-specific T-cell activation for the treatment of HPV16-driven malignancies. Clin Cancer Res 26:1953–1964
pubmed: 31964784
Nagarsheth NB, Norberg SM, Sinkoe AL et al (2021) TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. Nat Med 27:419–425
pubmed: 33558725
pmcid: 9620481
Sugiyama M, Bhawal UK, Kawamura M et al (2007) Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 45:116–122
pubmed: 16781026
Pérez-Islas E, García-Carrancá A, Acosta-Gio E et al (2022) Prognostic importance of DNA from human papillomavirus in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 27:e150–e158
pubmed: 35218643
pmcid: 8898585
Christianto S, Li KY, Huang TH et al (2022) The prognostic value of human papilloma virus infection in oral cavity squamous cell carcinoma: a meta-analysis. Laryngoscope S132:1760–1770
Nulton TJ, Kim NK, DiNardo LJ et al (2018) Patients with integrated HPV16 in head and neck cancer show poor survival. Oral Oncol 80:52–55
pubmed: 29706188
pmcid: 5930384
Shigeishi H, Sugiyama M (2016) Risk factors for oral human papillomavirus infection in healthy individuals: a systematic review and meta-analysis. J Clin Med Res 8:721–729
pubmed: 27635177
pmcid: 5012241
Holway GV, Hernandez SM (2018) Oral sex and condom use in a U.S. national sample of adolescents and young adults. J Adolesc Health 62:402–410
pubmed: 29174873
Hanley SJ, Yoshioka E, Ito Y et al (2015) HPV vaccination crisis in Japan. Lancet 385:2571
pubmed: 26122153
Barbour SE, Nakashima K, Zhang JB et al (1997) Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 8:437–460
pubmed: 9391754
Yanagita M, Kobayashi R, Kojima Y et al (2012) Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-γ upregulation. Cell Immunol 274:26–33
pubmed: 22425227
Dalla Torre D, Burtscher D, Sölder E et al (2019) The correlation between the quality of oral hygiene and oral HPV infection in adults: a prospective cross-sectional study. Clin Oral Investig 23:179–185
pubmed: 29574499
Toyama K, Maeda H, Sugita Y et al (2008) A research of the state of oral hygiene, lifestyle and human papillomavirus premlence among senior high school students (in Japanese). Tokai J School Health 32:3–12
Shigeishi H, Murodumi H, Ohta K et al (2021) Detection of HPV16 E6 DNA in periodontal pockets of middle-aged and older people. Oral Sci Int 18:50–55
Ortiz AP, González D, Vivaldi-Oliver J et al (2018) Periodontitis and oral human papillomavirus infection among Hispanic adults. Papillomavirus Res 5:128–133
pubmed: 29555599
pmcid: 5886954
Shigeishi H, Sugiyama M, Ohta K (2021) Relationship between the prevalence of oral human papillomavirus DNA and periodontal disease (review). Biomed Rep 14:40
pubmed: 33728046
pmcid: 7953200
Saini R, Osman NB, Ismail M et al (2011) Association of human papillomavirus with denture wearing. J Investig Clin Dent 2:241–247
pubmed: 25426895
Nishimura Y, Maeda H, Hattori M et al (2004) Human papillomavirus infection in the oral cavity of denture wearers (in Japanese). Nihon Hotetsu Shika Gakkai Zasshi 48:713–722
pubmed: 15818004
Nascimento ACDS, Nocetti MC, Lugo LZA et al (2019) Oncogenic high-risk human papillomavirus in patients with full denture. Braz Oral Res 33:e091
pubmed: 31778470
Pindborg JJ, Reichart PA, Smith CJ, et al. (1997) Histological typing of cancer and precancer of the oral mucosa, 2nd edn. World Health Organization International Classification of Tumours. Springer Verlag, Berlin, p 21–31
Lerman MA, Almazrooa S, Lindeman N et al (2017) HPV-16 in a distinct subset of oral epithelial dysplasia. Mod Pathol 30:1646–1654
pubmed: 28799537
Odell E, Kujan O, Warnakulasuriya S et al (2021) Oral epithelial dysplasia: recognition, grading and clinical significance. Oral Dis 27:1947–1976
pubmed: 34418233
Syrjänen S, Lodi G, von Bültzingslöwen I et al (2011) Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 17(Suppl 1):58–72
pubmed: 21382139
Khanal S, Trainor PJ, Zahin M et al (2017) Histologic variation in high grade oral epithelial dysplasia when associated with high-risk human papillomavirus. Oral Surg Oral Med Oral Pathol Oral Radiol 123:566–585
pubmed: 28407985
Sugiyama M, Bhawal UK, Dohmen T et al (2003) Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:594–600
pubmed: 12738951
Wei L, Griego AM, Chu M et al (2014) Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis 35:2373–2381
pubmed: 25064354
pmcid: 4178472
Su SC, Chang LC, Huang HD et al (2021) Oral microbial dysbiosis and its performance in predicting oral cancer. Carcinogenesis 42:127–135
pubmed: 32621740
Whitmore SE, Lamont RJ (2014) Oral bacteria and cancer. PLoS Pathog 10:e1003933
pubmed: 24676390
pmcid: 3968118
Olthof NC, Speel EJ, Kolligs J et al (2014) Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PLoS One 9:e88718
pubmed: 24586376
pmcid: 3933331
Olthof NC, Huebbers CU, Kolligs J et al (2015) Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer 136:E207–E218
pubmed: 25082736
Gray E, Pett MR, Ward D et al (2010) In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res 70:4081–4091
pubmed: 20442284
pmcid: 2872760